Stryker Corp stock steadies as RBC flags limited upside for 2026

Published on 09/17/2026 at 22:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Stryker Corp stock recently traded around USD 280 on September 17, 2026, after a year-to-date decline of almost 20 percent. Analysts still see upside, with an average price target of USD 374.88 pointing to more than 30 percent potential over time.

Fotorealistischer OP-Saal mit robotergestützter Chirurgie und sterilen Instrumenten — Fotorealistische Operationssaal-Szene veranschaulicht Stryker Corp. US8636671013 mit robotergestützter Chirurgie und moderner Medizintechnik-Ausstattung, Illustration mit AI erstellt.

Stryker Corp stock (ISIN US8636671013) is trading close to USD 280 on September 17, 2026, leaving the medical technology group almost 20 percent below its level at the start of the year and highlighting 2026 as a transition phase for the company.

Analysts frame 2026 as a transition year

According to Finimize on September 17, 2026, RBC Capital Markets describes 2026 as a transition year for Stryker after a cyberattack and softer demand in some orthopedics and peripheral vascular product lines, helping to explain why the stock is down more than 19 percent year to date and last traded around USD 280.

As MarketScreener reports on September 17, 2026, RBC sees limited upside for the remainder of 2026 but more promising prospects for 2027 if hospital equipment budgets and surgery schedules become easier to predict, positioning the current share price as a consolidation zone rather than a clear turning point.

Consensus targets still point to upside

According to the analyst consensus overview on MarketScreener dated September 17, 2026, Stryker shares most recently closed at USD 284.76, while the average analyst price target stands at USD 374.88, implying a potential upside of about 31.65 percent if the company delivers on its medium term growth story.

The same overview shows that 28 analysts currently cover Stryker with an overall opinion of Buy, and that the shares have gained about 4.17 percent over the last five trading days but are down roughly 19.97 percent since the start of 2026, underlining the contrast between the cautious near term and more constructive longer term views.

Stock holds near USD 280 after prior gains

Per data from Yahoo Finance on September 17, 2026, Stryker stock traded intraday around USD 282.23 at 1:10 p.m. Eastern time on the New York Stock Exchange, a decline of 0.89 percent from the prior close, indicating modest profit taking after recent gains in the mid USD 280 range.

The previous completed trading day on September 16, 2026 saw Stryker Corp close at USD 287.10 on the NYSE, up 1.99 percent from the prior session and after reaching an intraday high of USD 288.27, according to the German language market report on Ad-hoc-news, leaving the closing price slightly below the intraday high.

Closing price and valuation snapshot

As of September 17, 2026, the reference price for Stryker Corp stock is the intraday quote of USD 282.23 on the New York Stock Exchange in USD, with the prior closing price of USD 287.10 from September 16, 2026 and a day-to-day decline of 0.89 percent at 1:10 p.m. Eastern time underlining how quickly sentiment can swing around the mid USD 280 level.